Warren Lucinda bought CUE
September 29, 2025 · Form 4 insider transaction
Warren Lucinda bought 125,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 57 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderWarren Lucinda
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateSeptember 29, 2025
Filing dateNovember 25, 2025
Shares owned after125,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option becomes fully exercisable on the first anniversary of the grant date.